Yeah good plan Cane.
IMO though, I took the view that there were far better Aussie biotechs companies than Kazia at the moment with historical low share prices, competent management and late stage drugs and products. It has really worked well for me but I continue to watch Kazia and continue to hope for a change in management.
Just my opinion and definitely not advice
Dr Priscilla Brastianos, page-104
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)